vs
Side-by-side financial comparison of DENNY'S Corp (DENN) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
DENNY'S Corp is the larger business by last-quarter revenue ($113.2M vs $57.3M, roughly 2.0× RHYTHM PHARMACEUTICALS, INC.). DENNY'S Corp runs the higher net margin — 0.6% vs -83.0%, a 83.5% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 1.3%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -0.9%).
Denny's is an American table service diner-style restaurant chain. It operates over 1,400 restaurants in the United States, Canada, México, Puerto Rico, and several other international locations.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
DENN vs RYTM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $113.2M | $57.3M |
| Net Profit | $632.0K | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 9.2% | -82.2% |
| Net Margin | 0.6% | -83.0% |
| Revenue YoY | 1.3% | 36.9% |
| Net Profit YoY | -90.3% | -9.6% |
| EPS (diluted) | $0.01 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.3M | ||
| Q3 25 | $113.2M | $51.3M | ||
| Q2 25 | $117.7M | $48.5M | ||
| Q1 25 | $111.6M | $32.7M | ||
| Q4 24 | $114.7M | $41.8M | ||
| Q3 24 | $111.8M | $33.3M | ||
| Q2 24 | $115.9M | $29.1M | ||
| Q1 24 | $110.0M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $632.0K | $-52.9M | ||
| Q2 25 | $2.5M | $-46.6M | ||
| Q1 25 | $326.0K | $-49.5M | ||
| Q4 24 | $6.8M | $-43.3M | ||
| Q3 24 | $6.5M | $-43.6M | ||
| Q2 24 | $3.6M | $-32.3M | ||
| Q1 24 | $4.7M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | — | -82.2% | ||
| Q3 25 | 9.2% | -102.6% | ||
| Q2 25 | 7.3% | -93.4% | ||
| Q1 25 | 4.7% | -143.7% | ||
| Q4 24 | 12.6% | -98.6% | ||
| Q3 24 | 10.5% | -132.0% | ||
| Q2 24 | 7.9% | -139.2% | ||
| Q1 24 | 9.1% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | 0.6% | -103.1% | ||
| Q2 25 | 2.1% | -96.1% | ||
| Q1 25 | 0.3% | -151.4% | ||
| Q4 24 | 5.9% | -103.6% | ||
| Q3 24 | 5.8% | -131.2% | ||
| Q2 24 | 3.1% | -110.9% | ||
| Q1 24 | 4.3% | -544.4% |
| Q4 25 | — | $-0.73 | ||
| Q3 25 | $0.01 | $-0.82 | ||
| Q2 25 | $0.05 | $-0.75 | ||
| Q1 25 | $0.01 | $-0.81 | ||
| Q4 24 | $0.13 | $-0.71 | ||
| Q3 24 | $0.12 | $-0.73 | ||
| Q2 24 | $0.07 | $-0.55 | ||
| Q1 24 | $0.09 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-32.7M | $139.1M |
| Total Assets | $502.9M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | $1.1M | $314.5M | ||
| Q4 24 | $100.0K | $320.6M | ||
| Q3 24 | $2.9M | $298.4M | ||
| Q2 24 | $2.8M | $319.1M | ||
| Q1 24 | $2.8M | $201.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $270.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $139.1M | ||
| Q3 25 | $-32.7M | $148.8M | ||
| Q2 25 | $-34.6M | $-11.9M | ||
| Q1 25 | $-36.4M | $18.9M | ||
| Q4 24 | $-34.0M | $21.7M | ||
| Q3 24 | $-54.5M | $11.2M | ||
| Q2 24 | $-53.2M | $39.3M | ||
| Q1 24 | $-55.7M | $61.6M |
| Q4 25 | — | $480.2M | ||
| Q3 25 | $502.9M | $506.9M | ||
| Q2 25 | $491.1M | $372.7M | ||
| Q1 25 | $488.1M | $386.7M | ||
| Q4 24 | $496.3M | $392.3M | ||
| Q3 24 | $461.6M | $363.6M | ||
| Q2 24 | $459.9M | $381.8M | ||
| Q1 24 | $460.4M | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.0M | $-25.4M |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 14.1% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 25.28× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.4M | ||
| Q3 25 | $16.0M | $-26.6M | ||
| Q2 25 | $9.4M | $-23.3M | ||
| Q1 25 | $5.0M | $-40.4M | ||
| Q4 24 | $8.5M | $-18.8M | ||
| Q3 24 | $6.6M | $-25.2M | ||
| Q2 24 | $14.2M | $-29.1M | ||
| Q1 24 | $215.0K | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | $16.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 14.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 25.28× | — | ||
| Q2 25 | 3.79× | — | ||
| Q1 25 | 15.38× | — | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 3.97× | — | ||
| Q1 24 | 0.05× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DENN
| Franchisor Owned Outlet | $57.4M | 51% |
| Royalty | $27.7M | 25% |
| Advertising | $18.6M | 16% |
| Occupancy | $7.7M | 7% |
| Initial And Other Fees | $1.7M | 1% |
RYTM
Segment breakdown not available.
